Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-001778-40Phase 4Active
Phase 4, randomised trial of calcifediol in hip fracture and Vitamin D deficiency (VDD) (2 arms), sponsored by Leonor Cuadra Llopart. Primary endpoints: Functional gain at 6 months with calcifediol loading versus usual practice and Maintenance of functional benefit at 12 months. Started Oct 2017; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-001778-40.